Everand Logo

Welcome to Everand!

  • Discover this podcast and so much more

    Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

    Andreas Charidimou on new criteria for diagnosis of cerebral amyloid angiopathy

    Andreas Charidimou on new criteria for diagnosis of cerebral amyloid angiopathy

    FromThe Lancet Neurology in conversation with

    Start listeningView podcast show

    Andreas Charidimou on new criteria for diagnosis of cerebral amyloid angiopathy

    FromThe Lancet Neurology in conversation with

    ratings:
    Length:
    23 minutes
    Released:
    Jul 13, 2022
    Format:
    Podcast episode

    Description

    Andreas Charidimou (Massachusetts General Hospital, Boston, MA, USA) discusses an international collaborative study that presents new Boston criteria for diagnosis of cerebral amyloid angiopathy; the Article is published in the August issue of The Lancet Neurology. Read the full article:The Boston criteria version 2.0 for cerebral amyloid angiopathy
    Released:
    Jul 13, 2022
    Format:
    Podcast episode

    Titles in the series (100)

    Our Editors and and the journal’s authors explore their research and its impact on people’s health, health care, and health policy in this regular podcast.